Calamos Advisors LLC

SEC CIK: 0001316507
Latest filing: Jul 31, 2026

SEC filings (opens in a new tab)

RXDX holding history

Prometheus Biosciences, Inc. in every 13F filed by Calamos Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RXDX overview All 13F holders of RXDX Full Q2 2026 holdings

Shares (Q4 2022): 0; Sold out in Q4 2022
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q1 2022

Holdings of RXDX by Calamos Advisors LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q4 2022	0	$0	0.0%	−25,612−100.0%	Sold out	Holders
Q3 2022	25,612	$1.51M	<0.1%	+25,612	New	Holders
Q2 2022	0	$0	0.0%	−47,690−100.0%	Sold out	Holders
Q1 2022	47,690	$1.80M	<0.1%	+47,690	New	Holders